                         SEQUENCE LISTING

<110>  Roche Diabetes Care GmbH
       F. Hoffmann-LaRoche AG
 
<120>  Immunoassay for measuring C-peptide

<130>  66525P WO

<150>  EP 18 200 435.8
<151>  2018-10-15

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  31
<212>  PRT
<213>  Homo sapiens

<400>  1

Glu Ala Glu Asp Leu Gln Val Gly Gln Val Glu Leu Gly Gly Gly Pro 
1               5                   10                  15      


Gly Ala Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln 
            20                  25                  30      


<210>  2
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant C-peptide Mut2

<400>  2

Val Glu Leu Gly Gly Gly Pro Gly Ala Gly Ser Leu Gln Ala Leu Ala 
1               5                   10                  15      


<210>  3
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant C-peptide Mut3

<400>  3

Val Glu Leu Gly Gly Gly Pro Gly Ala Gly Ser Ile Gln Pro Leu Ala 
1               5                   10                  15      


<210>  4
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant C-peptide Mut5

<400>  4

Val Glu Leu Gly Gly Gly Pro Gly Ala Gly Ser Leu Ser Pro Leu Ala 
1               5                   10                  15      


<210>  5
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant C-peptide Mut6

<400>  5

Val Glu Leu Gly Gly Gly Pro Gly Ala Gly Ser Leu Ala Pro Leu Ala 
1               5                   10                  15      


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant C-peptide Mut18

<400>  6

Gly Gln Val Glu Cys Gly Gly Gly Pro Gly 
1               5                   10  


<210>  7
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant C-peptide Mut6-Cys

<400>  7

Cys Gly Ser Gly Ser Gly Ser Gly Ser Val Glu Leu Gly Gly Gly Pro 
1               5                   10                  15      


Gly Ala Gly Ser Leu Ala Pro Leu Ala 
            20                  25  


<210>  8
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant C-peptide Mut21

<400>  8

Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln 
1               5                   10      


<210>  9
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  variant C-peptide Mut22

<400>  9

Leu Ala Pro Leu Ala Leu Glu Gly Ser Leu Gln 
1               5                   10      


